General Session
Fedor Lurie, MD, PhD (he/him/his)
UIP Research Chair
Jobst Vascular Institute
University of Michigan
Toledo, Ohio, United States
Disclosure(s): Sigvar: Speaker/Honoraria
Kathleen Gibson, MD, FACS, FAVLS
Congress President
Lake Washington Vascular Surgeons
Bellevue, Washington, United States
Disclosure(s): Boston Scientific: Consultant/Advisory Board, Other Research Support, Speaker/Honoraria; Gore: Consultant/Advisory Board, Research Grant; Janssen: Speaker/Honoraria; Koya: Consultant/Advisory Board; Medtronic: Consultant/Advisory Board, Other Research Support, Research Grant, Speaker/Honoraria; Philips: Consultant/Advisory Board, Speaker/Honoraria
John Blebea, MD, MBA
Clinical Professor of Surgery
Central Michigan University
Central Michigan University
Saginaw, MI, United States
Disclosure(s):
The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.
Mark Meissner, MD
Peter Gloviczki Professor of Venous and Lymphatic Disorders
University of Washington
University of Washington School of Medicine
Seattle, WA, United States
Disclosure(s):
The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.
Alun Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FLSW, FACPh
Professor of Vascular Surgery
Section of Vascular Surgery, Imperial College London
Imperial College
London, England, United Kingdom
Disclosure(s):
The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.
Keynote - Debate Sessions
Chair: Fedor Lurie, MD, PhD (he/him/his) – Jobst Vascular Institute
Co-Chair: Kathleen Gibson, MD, FACS, FAVLS – Lake Washington Vascular Surgeons
Co-Chair: John Blebea, MD, MBA – Central Michigan University
Co-Chair: Mark Meissner, MD – University of Washington
Co-Chair: Alun H. Davies, MA DM DSc FRCS FACPh – Imperial College London
Chair: Fedor Lurie, MD, PhD (he/him/his) – Jobst Vascular Institute
Debate Moderator: Fedor Lurie, MD, PhD (he/him/his) – Jobst Vascular Institute
Debater - Con: Ahmed Gaweesh, MSc, MD, dECOP (he/him/his) – Alexandria University
Debater - Con: Kathleen Gibson, MD, FACS, FAVLS – Lake Washington Vascular Surgeons
Debater - Pro: Manj Gohel, MD FRCS FEBVS – Cambridge University Hospitals
Debater - Pro: Antonios Gasparis, MD – Stony Brook
Debate Moderator: Fedor Lurie, MD, PhD (he/him/his) – Jobst Vascular Institute
Debater - Con: Nicos Labropoulos, PhD (he/him/his) – Stony Brook Medicine
Faculty: Manj Gohel, MD FRCS FEBVS – Cambridge University Hospitals
